The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
The private funding rose 38% amid growing international collaborations and CDMO demand
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
The move follows encouraging Phase I data and a series of regulatory wins from the U.S. Food and Drug Administration
The study will test the company’s lead product, ZI-MA4-1, in patients with advanced solid cancers
PiNACLE is a head-to-head study comparing its next-generation CAR T-cell therapy against established therapies liso-cel and axi-cel in patients with relapsed or refractory large B-cell lymphoma
The acquisition brings Lilly a novel in vivo cell therapy platform built around engineered circular RNA and proprietary lipid nanoparticles
The goal of the agreement is to advance cell and gene therapy accessibility by enabling scalable and efficient cell therapy manufacturing
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
